Form 8-K - Current report:
SEC Accession No. 0000917520-23-000012
Filing Date
2023-02-22
Accepted
2023-02-22 06:15:31
Documents
14
Period of Report
2023-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K iart-20230222.htm   iXBRL 8-K 52549
2 EX-99.1 ex991q42022earnings.htm EX-99.1 283230
  Complete submission text file 0000917520-23-000012.txt   528605

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT iart-20230222.xsd EX-101.SCH 2225
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT iart-20230222_def.xml EX-101.DEF 14477
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT iart-20230222_lab.xml EX-101.LAB 28047
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT iart-20230222_pre.xml EX-101.PRE 14984
8 EXTRACTED XBRL INSTANCE DOCUMENT iart-20230222_htm.xml XML 10588
Mailing Address 1100 CAMPUS ROAD PRINCETON NJ 08540
Business Address 1100 CAMPUS ROAD PRINCETON NJ 08540 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 23650459
SIC: 3841 Surgical & Medical Instruments & Apparatus